Cardiff Oncology Inc (CRDF)
3.63
-0.11
(-2.94%)
USD |
NASDAQ |
May 17, 16:00
3.64
+0.01
(+0.28%)
After-Hours: 20:00
Cardiff Oncology Free Cash Flow: -30.62M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -30.62M |
| December 31, 2023 | -31.47M |
| September 30, 2023 | -33.79M |
| June 30, 2023 | -33.45M |
| March 31, 2023 | -33.07M |
| December 31, 2022 | -34.83M |
| September 30, 2022 | -32.86M |
| June 30, 2022 | -30.49M |
| March 31, 2022 | -27.78M |
| December 31, 2021 | -23.24M |
| September 30, 2021 | -20.93M |
| June 30, 2021 | -19.05M |
| March 31, 2021 | -19.04M |
| December 31, 2020 | -16.53M |
| September 30, 2020 | -14.62M |
| June 30, 2020 | -14.19M |
| March 31, 2020 | -13.34M |
| December 31, 2019 | -13.34M |
| September 30, 2019 | -13.67M |
| June 30, 2019 | -13.90M |
| March 31, 2019 | -13.71M |
| December 31, 2018 | -13.20M |
| September 30, 2018 | -12.89M |
| June 30, 2018 | -16.12M |
| March 31, 2018 | -17.47M |
| Date | Value |
|---|---|
| December 31, 2017 | -23.38M |
| September 30, 2017 | -29.12M |
| June 30, 2017 | -29.58M |
| March 31, 2017 | -33.37M |
| December 31, 2016 | -31.86M |
| September 30, 2016 | -30.63M |
| June 30, 2016 | -29.16M |
| March 31, 2016 | -26.65M |
| December 31, 2015 | -24.36M |
| September 30, 2015 | -20.56M |
| June 30, 2015 | -18.37M |
| March 31, 2015 | -15.15M |
| December 31, 2014 | -13.09M |
| September 30, 2014 | -11.03M |
| June 30, 2014 | -9.828M |
| March 31, 2014 | -9.162M |
| December 31, 2013 | -7.967M |
| September 30, 2013 | -7.411M |
| June 30, 2013 | -6.591M |
| March 31, 2013 | -5.928M |
| December 31, 2012 | -5.209M |
| September 30, 2012 | -4.352M |
| June 30, 2012 | -3.256M |
| March 31, 2012 | -2.365M |
| December 31, 2011 | -1.932M |
Free Cash Flow Range, Past 5 Years
-34.83M
Minimum
Dec 2022
-13.34M
Maximum
Dec 2019
-23.51M
Average
-22.09M
Median
Free Cash Flow Benchmarks
| BioVie Inc | -41.11M |
| Perspective Therapeutics Inc | -23.28M |
| Biolase Inc | -14.37M |
| Tenon Medical Inc | -12.54M |
| Adial Pharmaceuticals Inc | -6.807M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -7.74M |
| Cash from Investing (Quarterly) | 4.636M |
| Cash from Financing (Quarterly) | 0.107M |
| Free Cash Flow Per Share (Quarterly) | -0.175 |
| Free Cash Flow to Equity (Quarterly) | -7.82M |
| Free Cash Flow Yield | -18.88% |